Advanced search×

Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study.

Am J Obstet Gynecol 206(2):141.e1-8 (2012) PMID 22030316

To determine the incidence and risk factors for neurodevelopmental impairment (NDI) in children with hemolytic disease of the fetus/newborn treated with intrauterine transfusion (IUT).

Copyright © 2012 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.ajog.2011.09.024
Version: za2963e q8za2 q8zb0 q8zc0 q8zd6 q8ze0 q8zf2 q8zgd

Similar articles you may find interesting…

  1. Recurrence and long-term maternal health risks of hypertensive disorders of pregnancy: a population-based study.

    Am J Obstet Gynecol 206(2):143.e1-8 (2012) PMID 22036665

    Preeclampsia in the first pregnancy increased the risk of recurrence in later pregnancies (relative risk, 6.6; 95% confidence interval, 5.5-7.9) compared with a normotensive first pregnancy. Women with a history of preeclampsia or nonproteinuric hypertension had an unfavorable cardiovascular risk pr...
  2. Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization

    Am J Obstet Gynecol 185(5):4 (2001) PMID 11717631

    Gestational age at the Doppler study ranged from 19 to 36 weeks. Forty-six fetuses (72%) were not or mildly anemic; 7 fetuses (11%) were moderately anemic, and 11 fetuses (17%) were severely anemic. Middle cerebral artery peak systolic velocity for the prediction of severe, moderate, and mild anemia...
  3. The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomes.

    Am J Obstet Gynecol 206(2):145.e1-9 (2012) PMID 22000668

    Cord blood IL-6 and G-CSF were higher than maternal levels. Antibiotic treatment lowered only maternal G-CSF (P = .01). Elevated maternal cytokine levels were associated with delivery within 7 days and with development of chorioamnionitis. All umbilical cord blood markers were increased with amnioni...